Paleo
Meilrijk 98
3290 Diest
BE
Paleo
Foundation date
26/10/2020
Sector
#Biotechnology - otherSubsector
Paleo researches and develops new functional ingredients to improve plant-based meat and fish alternatives. Through precision fermentation, Paleo produces specific meat and fish proteins which are 100% bio-identical to animal proteins and 100% GMO-free.
Our primary focus is on myoglobin, a heme protein present in animal muscle tissue. Adding myoglobin makes plant-based foods look and taste more like ‘real’ meat or fish (color, smell, taste, aromatic experience) and provides added nutritional value (essential nutrients).
Precision fermentation is a proven, innovative technology that uses micro-organisms, such as yeasts, that are programmed to produce selected target proteins. This technology is versatile, scalable, and already used in many industries such as the production of pharmaceuticals (e.g. insulin).
Compared to the conventional farming of animals, precision fermentation has a significantly lower environmental impact (lower greenhouse gas emissions, less land use, less water consumption) and offers benefits for public health (containing no antibiotics or hormones).
Paleo contributes to global food security and reduces the negative impact of the conventional production of animal proteins on animal welfare, the environment, biodiversity, and human health.
By focusing on sustainability, health and food security, Paleo contributes directly or indirectly to the realization of at least 11 of the 17 United Nations Sustainable Development Goals.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
23 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Wednesday November 20th 2024
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
22/11/24
Flemish Brabant
ERC-funded postdoctoral position on engineering gut bacteria for live biotherapeutic applications
Permanent
VIB -
More info?
Ellen Telleir
Communication Coordinator